Illumigyn Overview
Illumigyn develops technology in the field of gynecology, offering a comprehensive platform solution featuring the Gynescope System, an FDA-cleared gynecology endoscope and cloud platform service. The Illumigyn Gynescope System uses a novel technology that creates high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy. The images are uploaded to the cloud for viewing and analysis by any doctor across the globe. With Illumigyn, the patient has more control and a close view of the procedure, with immediate access to a second opinion by AI clinical decision support software, without undergoing another procedure. The company aims to use its technological know-how and expertise to create an ecosystem that will empower all facets of women's health, making it accessible and affordable for every woman worldwide.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Gynescope remote systems deployed to save African women
Illumigyns gynecological imaging platform, Gynescope, will be distributed across Africa to improve early diagnosis and detection rates of cervical cancer. Illumigyn and Peramare Enterprises signed a distribution agreement for 20,000 Gynescope units, aiming to ensure the early detection of cervical cancer in women in Africa. The system allows for high-resolution imaging of the cervix, vagina, and external genitalia, with the images uploaded to Illumigyns secure cloud for remote diagnostics and consultations. The deal was made possible with credit backing from Afreximbank, a pan-African multilateral trade finance institution. This initiative is expected to have significant health and socio-economic benefits for women in Africa.
CustomersPartners
growth-positive
illumigyn™ Partners with Peramare Enterprises Ltd. and Supported by Afreximbank to Deploy Its Cutting-Edge Gynecological Imaging System and Cloud-Based Platform throughout Africa
illumigyn has signed a distribution agreement with Peramare Enterprises to deploy 20,000 Gynescopes™ systems across Africa. The African Export-Import Bank will provide financial backing for the agreement. The World Health Organization states that cervical cancer is a significant public health threat in Africa, and illumigyn aims to combat this by providing accessible screenings and remote-diagnostics platforms. The Gynescopes™ system digitally documents the cervix, vagina, and external genitalia, enabling more accurate pap smears. The system can be operated by trained caregivers, allowing women in remote locations to be screened and diagnosed. The partnership between illumigyn, Peramare Enterprises, and Afreximbank aims to improve access to healthcare and save womens lives in Africa.
CustomersPartners
growth-positive
illumigyn raises $33 million to help women with affordable medical care
Illumigyn, a remote gynecological imaging platform, has raised $33 million in a funding round that included participation from the Yozma Group Korea and Ubicom Holdings Japan. The funding will be used to deploy its platform in the United States, United Arab Emirates, India, Singapore, and South Korea. The platform features the Gynescope System, a gynecology endoscope and cloud platform service with an accompanying mobile app that can digitally document the cervix, vagina, and external genitals. The investment will also support R&D efforts for the company to provide women across the world the best care for cancers and other diseases.
InvestmentExpand
growth-positive
Israeli women's health startup to deliver devices to Gulf
Israeli women’s health startup Illumigyn has signed a memorandum of understanding with Dubai-based company DHI2048 to deliver 2,500 high-tech speculums to the Gulf states. The deal is valued at an estimated $150 million. Illumigyns Gynescope device enables high-end imaging of the cervix, vagina, and external genitalia, allowing for remote diagnosis and reducing the need for invasive procedures. The partnership aims to revolutionize womens healthcare and establish Dubai as a healthcare hub for the region.
PartnersCustomers
growth-positive
illumigyn signs MoU to deploy 2,500 units of its "gynecology endoscope" cloud platform in UAE
Israeli company illumigyn has signed a Memorandum of Understanding with Dubai-based company DHI 2048 to deploy 2,500 units of its cloud-based gynecological imaging service. The partnership aims to improve womens healthcare in the region and make Dubai a healthcare hub. The Gynescope System provided by illumigyn offers an end-to-end gynecological imaging service, including image documentation, archiving, and sharing. The MoU was signed one year after the Abraham Accords, which marked the beginning of open economic relations between Israel and the UAE. The collaboration agreement between illumigyn and DHI 2048 is seen as a testament to the growing ties between the two countries.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $38M |
| Last funding | $33M |
| Stage | A |
| Rounds | 2 |
| Investors | 2 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.illumigyn.com |
Locations
Neve Ilan, Israel
Photos & Videos
3 item(s)
